海得控制(002184.SZ):2月18日-19日控股股東及其一致行動人通過大宗交易減持331.5萬股
格隆匯 2 月 21日丨海得控制(002184.SZ)公佈,近日,公司收到公司控股股東的一致行動人上海定增1號資產管理計劃管理人出具的《上海證券聚贏定增1號集合資產管理計劃減持海得控制股份進展情況吿知函》,截止2021年2月21日,此次減持計劃的減持期限已屆滿。
此外,公司收到控股股東許泓、郭孟榕出具的《關於持股比例變動的吿知函》,2021年2月18日至2021年2月19日期間,許泓、郭孟榕及其一致行動人通過大宗交易方式累計減持331.5萬股,持股比例累計變動超過1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.